MENU
OPRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

OPRX stock forecast, quote, news & analysis

OptimizeRx Corp is engaged in the healthcare market in the United States... Show more

OPRX
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
A.I.Advisor
a Summary for OPRX with price predictions
Jul 02, 2026

OPRX's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for OPRX turned positive on June 26, 2026. Looking at past instances where OPRX's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 29, 2026. You may want to consider a long position or call options on OPRX as a result. In of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

OPRX moved above its 50-day moving average on June 30, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where OPRX advanced for three days, in of 266 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where OPRX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

OPRX broke above its upper Bollinger Band on June 30, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.678) is normal, around the industry mean (7.366). OPRX has a moderately low P/E Ratio (13.000) as compared to the industry average of (50.081). OPRX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.153). Dividend Yield (0.000) settles around the average of (0.045) among similar stocks. P/S Ratio (0.831) is also within normal values, averaging (5.651).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. OPRX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OPRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 99, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Teladoc Health (NYSE:TDOC).

Industry description

This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.

Market Cap

The average market capitalization across the Services to the Health Industry Industry is 2.39B. The market cap for tickers in the group ranges from 708 to 31.31B. VEEV holds the highest valuation in this group at 31.31B. The lowest valued company is OTRKQ at 708.

High and low price notable news

The average weekly price growth across all stocks in the Services to the Health Industry Industry was 7%. For the same Industry, the average monthly price growth was 10%, and the average quarterly price growth was -5%. MGRX experienced the highest price growth at 27%, while HTFL experienced the biggest fall at -20%.

Volume

The average weekly volume growth across all stocks in the Services to the Health Industry Industry was -29%. For the same stocks of the Industry, the average monthly volume growth was -24% and the average quarterly volume growth was -5%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 77
Price Growth Rating: 57
SMR Rating: 88
Profit Risk Rating: 98
Seasonality Score: -8 (-100 ... +100)
View a ticker or compare two or three
OPRX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a provider of unique consumer and physician platforms to help patients better afford and comply with their medicines and healthcare products

Industry ServicestotheHealthIndustry

Profile
Details
Industry
Data Processing Services
Address
260 Charles Street
Phone
+1 248 651-6568
Employees
133
Web
https://www.optimizerx.com
OPRX's MACD Histogram crosses above signal line